VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+0.85%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$191M
AUM Growth
-$20.5M
(-9.7%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-6.22%
Top 10 Holdings %
Top 10 Hldgs %
8%
Holding
450
New
8
Increased
100
Reduced
215
Closed
125
Top Buys
| 1 |
Brookfield Infrastructure
BIPC
|
$1.15M |
| 2 |
ECC
Eagle Point Credit Co
ECC
|
$1.05M |
| 3 |
OXLC
Oxford Lane Capital
OXLC
|
$1.03M |
| 4 |
ORAN
Orange
ORAN
|
$395K |
| 5 |
SNP
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
|
$391K |
Top Sells
| 1 |
Delek Logistics
DKL
|
$2.05M |
| 2 |
Western Midstream Partners
WES
|
$788K |
| 3 |
CNXM
CNX Midstream Partners LP
CNXM
|
$744K |
| 4 |
OSB
Norbord Inc.
OSB
|
$657K |
| 5 |
Lamar Advertising Co
LAMR
|
$515K |
Sector Composition
| 1 | Healthcare | 32.34% |
| 2 | Real Estate | 18.02% |
| 3 | Energy | 12.43% |
| 4 | Materials | 10.7% |
| 5 | Financials | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Rhythm Pharmaceuticals
RYTM
$6.78B
| $333K | 0.17% |
15,384
-2,100
| -12% | -$45.5K |
|
202
FibroGen
FGEN
$48.9M
| $332K | 0.17% |
323
-44
| -12% | -$45.2K |
|
203
Geron
GERN
$893M
| $331K | 0.17% |
190,263
-25,936
| -12% | -$45.1K |
|
204
Bain Capital Specialty
BCSF
$1.02B
| $329K | 0.17% |
32,224
-4,571
| -12% | -$46.7K |
|
|
ICPT
205
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $322K | 0.17% |
7,774
+655
| +9% | +$27.1K |
|
206
Editas Medicine
EDIT
$248M
| $320K | 0.17% |
11,417
-1,570
| -12% | -$44K |
|
207
Prothena Corp
PRTA
$460M
| $318K | 0.17% |
31,875
-4,348
| -12% | -$43.4K |
|
208
Intellia Therapeutics
NTLA
$1.29B
| $317K | 0.17% |
15,927
-2,173
| -12% | -$43.3K |
|
209
Kodiak Sciences
KOD
$556M
| $315K | 0.17% |
5,316
-710
| -12% | -$42.1K |
|
210
BlackRock Debt Strategies Fund
DSU
$547M
| $313K | 0.16% |
31,521
-8,737
| -22% | -$86.8K |
|
211
Cytokinetics
CYTK
$6.34B
| $312K | 0.16% |
14,417
-1,971
| -12% | -$42.7K |
|
212
Gossamer Bio
GOSS
$668M
| $312K | 0.16% |
25,129
-3,425
| -12% | -$42.5K |
|
213
MeiraGTx Holdings
MGTX
$619M
| $309K | 0.16% |
23,357
-3,188
| -12% | -$42.2K |
|
214
Vir Biotechnology
VIR
$732M
| $309K | 0.16% |
9,001
-1,225
| -12% | -$42.1K |
|
215
Kezar Life Sciences
KZR
$29.8M
| $308K | 0.16% |
6,369
-869
| -12% | -$42K |
|
|
SYRS
216
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $308K | 0.16% |
3,484
-474
| -12% | -$41.9K |
|
217
Axsome Therapeutics
AXSM
$6.25B
| $304K | 0.16% |
4,269
-570
| -12% | -$40.6K |
|
218
Crinetics Pharmaceuticals
CRNX
$3.35B
| $304K | 0.16% |
19,371
-2,655
| -12% | -$41.7K |
|
219
CEL-SCI Corp
CVM
$72.2M
| $304K | 0.16% |
795
-109
| -12% | -$41.7K |
|
|
ATNX
220
DELISTED
Athenex, Inc. Common Stock
ATNX
| $304K | 0.16% |
1,255
-172
| -12% | -$41.7K |
|
|
BHVN
221
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $304K | 0.16% |
4,671
-647
| -12% | -$42.1K |
|
|
PHD
222
Pioneer Floating Rate Fund
PHD
$123M
| $301K | 0.16% |
29,832
-11,979
| -29% | -$121K |
|
223
Apellis Pharmaceuticals
APLS
$3.55B
| $300K | 0.16% |
9,947
-1,352
| -12% | -$40.8K |
|
224
Korro Bio
KRRO
$312M
| $297K | 0.16% |
309
-43
| -12% | -$41.3K |
|
225
Revolution Medicines
RVMD
$7.57B
| $297K | 0.16% |
8,538
-1,163
| -12% | -$40.5K |
|